Groundwork BioAg expands Global commercialisation of mycorrhizal inoculants
Groundwork BioAg announced that its flagship mycorrhizal inoculant – Rootella – has been approved for commercialisation in China, Argentina, and South Africa, expanding farmers’ access to a climate-smart solution to optimise plant and soil health, adding approximately 677 million acres (274 million hectares) of harvested cropland to the company’s potential customer base.
Over the last few years, Groundwork BioAg expanded commercialisation in the United States, Brazil, India, Canada, Ukraine, and other countries in Europe. With the addition of China, Argentina, and South Africa, the company and its local partners can offer farmers – including those in four of the top agricultural markets – access to the most highly concentrated mycorrhizal inoculant products available.
“Growers face mounting environmental and financial pressures to produce the food, fuel and fibre the world demands,” said Hanan Dor, Chief Commercial Officer at Groundwork BioAg. “As the leading mycorrhizal inoculant supplier, Groundwork BioAg is committed to partnering with local distributors to provide nature-based solutions that fit into modern farming practices and align with the world’s sustainability goals.”
